Basic Information
| LncRNA/CircRNA Name | PANDAR |
| Synonyms | PANDAR, PANDA |
| Region | GRCh38_6:36673621-36675126 |
| Ensemble | ENSG00000281450 |
| Refseq | NR_109836 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | acute myeloid leukemia |
| ICD-0-3 | NA |
| Methods | RNAi, qPCR, other |
| Sample | Bone marrow |
| Expression Pattern | up-regulated |
| Function Description | These results revealed that PANDAR was overexpressed in AML, and that higher PANDAR expression was associated with poor clinical outcome. Our study therefore suggests that PANDAR expression is a promising biomarker for prognostic prediction for AML. |
| Pubmed ID | 30464600 |
| Year | 2018 |
| Title | Overexpression of lncRNA PANDAR Predicts Adverse Prognosis in Acute Myeloid Leukemia |
External Links
| Links for PANDAR | GenBank HGNC NONCODE |
| Links for acute myeloid leukemia | OMIM COSMIC |